Underreporting of Suspected Adverse Drug Reactions to Newly Marketed ("Black Triangle") Drugs in General Practice: Observational Study
BMJ
doi 10.1136/bmj.317.7151.119
Full Text
Open PDFAbstract
Available in full text
Date
July 11, 1998
Authors
Publisher
BMJ